# TRIAMTERENE AND HYDROCHLOROTHIAZIDE
> **ANDA214611** · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2025-01-28
## Drug
- **FDA Application Number:** ANDA214611
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- **Generic name:** TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** HYDROCHLOROTHIAZIDE; TRIAMTERENE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** MACLEODS PHARMS LTD
- **Manufacturer:** Macleods Pharmaceuticals Limited
- **First approval:** 2025-01-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214611)
---
*AI Analytics · CC0 1.0*